Eudemonia 2026 Draws Thousands As The Longevity Boom Gains Momentum

About 8,000 people attended Eudēmonia 2026 in West Palm Beach, where longevity programming, workouts and more than 160 brands filled a three-day event.

Intensive Blood Pressure Control Gets A Win In Stroke Survivors

In OPTIMAL-STROKE, a systolic target below 120 mm Hg reduced major cardiovascular events versus below 140, with a renal-function trade-off.

Safety Of Controversial Vasculitis Drug Bolstered In Dedicated Trial

Interim AvacoStar results found more liver abnormalities with avacopan, but rates were low; the safety study remains ongoing through 2030.

I Recommend This Yoga Practice To My Clients Who Are Desperate For Better Sleep

A yoga therapist recommends guided yoga nidra for relaxation and sleep. Here is what the practice involves, what the report says and what remains uncertain.

Ordinary Wisdom: The Man In The Bib Overalls

A Sixty and Me essay remembers Earl, an Arizona farmer and self-taught pilot, and reflects on experience, curiosity and assumptions about expertise.

Study Maps Key Regions Driving Inflammation In Aging Hearts

A JAX study finds age-related inflammation and scarring signals concentrated in the aortic valves and root of mouse hearts.

Avoiding Chemo In Breast Cancer; Psychedelic Medication For Depression

A Texas Tech podcast reviewed research on PET-guided chemotherapy reduction in HER2-positive breast cancer and intranasal mebufotenin for depression.

Oral LSD Drug Hits Phase III Endpoints In Anxiety, Depression

Definium says its single-dose oral LSD formulation met primary endpoints in two Phase III trials; the results have not yet established approval or long-term safety.

Dismantling Ageism From Within After 60

A Sixty and Me essay urges people over 60 to challenge internalized age-related beliefs through self-care, creative expression and other practices.

Obesity Drugs May Help Protect Memory And Cognitive Abilities

A Science review examines whether GLP-1 obesity drugs could protect cognition, while human evidence remains mixed and Alzheimer’s trials were negative.